Article Details
Retrieved on: 2023-11-06 17:02:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
These 2 studies are timely in the context of recently published phase 3 results testing monoclonal antibodies against amyloid-β, 1 of which (lecanemab) ...
Article found on: jamanetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here